Vertex Pharmaceuticals

Vertex Pharmaceuticals, Inc. is the American biopharmaceutical a company based Boston in, Massachusetts.

History

2022: Vertex bought ViaCyte for $320 million

On July 11, 2022, Vertex announced the purchase of ViaCyte for $320 million. The deal will close at the end of 2022, provided that its participants receive approval from antitrust authorities. Read more here.

2020: Attempted domain capture VertexMedical.com

All-Russian Intellectual Property Organization (WIPO) reviewed domain a complaint about the domain within the framework of the UDRP Unified Dispute Resolution Policy VertexMedical.com. This was announced on November 19, 2020. National Internet Domain Coordination Center (CC) The complaint was filed by pharmaceutical Vertex Pharmaceuticals, which is a member of the industry. Its capitalization level is estimated at 58 billion. dollars The defendant was a domain registrar - the Pakistani medical Vertex Medical with about 100 employees and an annual turnover of about $6 million.

WIPO arbitrator Andrew Lothian refused to admit that the domain was VertexMedical.com registered or used for unlawful purposes and to the detriment of the interests of Vertex Pharmaceuticals. He noted that the Vertex Medical website operates on the domain, which regularly performs its work, does not violate laws and simply has nothing to do with Vertex Pharmaceuticals.

As for the possible collision due to the coincidence of names, then here Andrew Lothian took the side of the defendant. He stated that the Latin word vertex in medicine means the parietal region of the head. Therefore, for the medical business, it is a common word and cannot be considered exclusive ownership of any company. As a result, the WIPO arbitrator not only left the domain to a Pakistani company, but also found Vertex Pharmaceuticals guilty of attempting to retry the domain name hijacking. Domain Name Wire, reporting this news, notes that Vertex Pharmaceuticals lawyers are by no means new to domain disputes. Earlier, the company had already filed 7 UDRP complaints and in all cases achieved victory.